Patologia
Departament
Fondazione IRCCS Istituto Nazionale dei Tumori
Milán, ItaliaPublicaciones en colaboración con investigadores/as de Fondazione IRCCS Istituto Nazionale dei Tumori (4)
2024
-
Soluble galectin-3 as a microenvironment-relevant immunoregulator with prognostic and predictive value in lung adenocarcinoma
Molecular Oncology, Vol. 18, Núm. 1, pp. 190-215
2021
-
Frequency and prognostic impact of alk amplifications and mutations in the european neuroblastoma study group (siopen) high-risk neuroblastoma trial (hr-nbl1)
Journal of Clinical Oncology, Vol. 39, Núm. 30, pp. 3377-3390
2014
-
MRP1 overexpression determines poor prognosis in prospectively treated patients with localized high-risk soft tissue sarcoma of limbs and trunk wall: An ISG/GEIS study
Molecular Cancer Therapeutics, Vol. 13, Núm. 1, pp. 249-259
2010
-
Triple-negative breast cancer: Present challenges and new perspectives
Molecular Oncology, Vol. 4, Núm. 3, pp. 209-229